Home / Health / Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease

Bacteriophage targeting of gut bacterium attenuates alcoholic liver disease



  • first

    Lozano, R. et al. Global and regional mortality from 235 causes of death for 20 age groups 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380 2095-2128 (2012). [19659004] 2.

    Lee, BP, Vittinghoff, E., Dodge, J.L., Cullaro, G. & Terrault, NA National trends and long-term outcomes of liver transplantation for alcohol-associated liver disease in the United States. JAMA Intern. Med . 1

    79 340–348 (2019).

  • 3rd

    Rehm, J. et al. Load of illnesses associated with alcohol use disorders in the United States. Alcohol. Clin. Exp. Res . 38 1068–1077 (2014).

  • 4th

    Llopis, M. et al. Intestinal microbiota contributes to individual susceptibility to alcoholic liver disease. Gut 65 830–839 (2016).

  • 5th

    Ike, Y., Clewell, D. B., Segarra, R. A. & Gilmore, M. S. Genetic analysis of the pAD1 hemolysin / bacteriocin determinant in Enterococcus faecalis : Tn 917 insertional mutagenesis and cloning . J. Bacteriol . 172 155–163 (1990).

  • 6th

    Tang, W. & van der Donk, W. A. ​​The sequence of the enterococcal cytolysin produces unusual lantionine stereochemistry. Nat. Chem. Biol . 9 157–159 (2013).

  • 7th

    Maddrey, W. C. et al. Corticosteroid treatment of alcoholic hepatitis. Gastroenterology 75 193–199 (1978).

  • 8th

    Dominguez, M. et al. A new scoring system for prognostic stratification of patients with alcohol hepatitis. Am. J. Gastroenterol . 103 2747-2756 (2008).

  • ninth

    Thursz, M. R. et al. Prednisolone or pentoxifylline for alcoholic hepatitis. N. Engl. J. Med . 372 1619–1628 (2015).

  • 10th

    Mathurin, P. & Lucey, M. R. Management of alcoholic hepatitis. J. Hepatol . 56 S39 – S45 (2012).

  • eleventh

    Llorente, C. et al. Gastric acid suppression promotes alcoholic liver disease by inducing intestinal overgrowth Enterococcus . Nat Commun . 8 837 (2017).

  • 12th

    Gilmore, M. S. et al. Genetic structure of Enterococcus faecalis plasmid pAD1-encoded cytolytic toxin system and its relationship to lantibiotic determinants. J. Bacteriol . 176 7335–7344 (1994).

  • thirteenth

    Cox, CR, Coburn, PS & Gilmore, MS Enterococcal cytolysin: a novel two-component peptide system that serves as a bacterial defense against eukaryotic and prokaryotic cells. Curr. Protein Pept. Sci . 6 77–84 (2005).

  • fourteenth

    Van Tyne, D., Martin, M. J. & Gilmore, M. S. Structure, function and biology of the Enterococcus faecalis cytolysin. Toxins 5 895–911 (2013).

  • 15th

    Bertola, A., Mathews, S., Ki, S.H., Wang, H. & Gao, B. Mouse model for feeding chronic and binge ethanol (NIAAA model). Nat. Protoc. 8 627–637 (2013).

  • 16th

    Ogilvie, L. A. & Jones, B. V. The human gut virus: a multifaceted majority. Front. Microbiol . 6 918 (2015).

  • 17th

    Chatterjee, A. et al. Bacteriophage resistance alters antibiotic-mediated intestinal expansion of enterococci. Infect. Immune . 87 e00085-19 (2019).

  • 18th

    Poindexter, J. S. Biological Properties and Classification of the Group Caulobacter . Bacteriol. Rev. . 28 231–295 (1964).

  • 19th

    Shin, J. et al. Analysis of mouse gut microbiome using full length 16S rRNA amplicon sequence. Sci. Rep . 6 29681 (2016).

  • 20th

    Human Microbiome Project Consortium. Structure, function and diversity of the healthy human microbiome. Nature 486 207–214 (2012).

  • 21st

    Marcuk, L. M. et al. Clinical studies on the use of bacteriophages in the treatment of cholera. Bull. World Health Organization . 45 77–83 (1971).

  • 22nd

    Sarker, S. A. et al. Oral phage therapy of acute bacterial diarrhea with two colophagic preparations: a randomized study in Bangladesh from children. EBioMedicine 4 124–137 (2016).

  • 23rd

    Dalmasso, M., Hill, C. & Ross, R. P. Uses intestinal bacteriophages for human health. Trends Microbiol . 22 399–405 (2014).

  • 24th

    Ujmajuridze, A. et al. Adapted bacteriophages for the treatment of urinary tract infections. Front. Microbiol . 9 1832 (2018).

  • 25th

    Khawaldeh, A. et al. Bacteriophage therapy for refractory Pseudomonas aeruginosa urinary tract infection. J. Med. Microbiol . 60 1697–1700 (2011).

  • 26th

    Schooley, R. T. et al. Development and use of personalized bacteriophage-based therapeutic cocktails to treat a patient with a spread resistant Acinetobacter baumannii infection. Antimicrob. Agents Chemother . 61 e00954-17 (2017).

  • 27th

    Dedrick, R. M. et al. Constructed bacteriophages for the treatment of a patient with a spread drug resistant Mycobacterium abscessus . Nat Med . 730–733 (2019).

  • 28th

    Fish, R. et al. Compassionate use of bacteriophage therapy for wound treatment as an effective step in the course of clinical trials. Methods Mol. Biol . 1693 159-170 (2018).

  • 29th

    Górski, A. et al. Phages and immune modulation. Future Microbiol . 12 905–914 (2017).

  • 30 °.

    Brandl, K. et al. Dysregulation of serum bile acids and FGF19 in alcoholic hepatitis. J. Hepatol . 69 396–405 (2018).

  • 31st

    Gao, B. et al. Serum and fecal oxy lipids in patients with alcohol-related liver disease. Dig. Haze. Sci . 64 1878–1892 (2019).

  • 32nd

    Lang, S. et al. Intestinal fungal dysbiosis and systemic immune response to fungi in patients with alcoholic hepatitis. Hepatology (2019).

  • 33rd

    Ball, SA, Tennen, H., Poling, JC, Kranzler, HR & Rounsaville, BJ Personality, temperament and character dimensions and DSM-IV personality disorders in addicts. J. Abnorm. Psychol . 106 545–553 (1997).

  • 34th

    Krieg, L. et al. Mutation of gastric hydrogen potassium ATPase alpha subunit causes iron deficiency anemia in mice. Blood 118 6418–6425 (2011).

  • 35th

    Gill, J. J. et al. Caulobacter crescentus phage phiCbK: genomics of a canonical phage. BMC Genomics 13 542 (2012).

  • 36th

    Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. Complete bacterial units with multiplex MinION sequencing. Microb. THROUGH . 3 e000132 (2017).

  • 37th

    Wick, R. R., Judd, L. M., Gorrie, C. L. & Holt, K. E. Unicycles: resolving bacterial units from short and long sequence reads. PLOS Comput. Biol . 13 e1005595 (2017).

  • 38th

    Walker, B. J. et al. Pilon: an integrated tool for comprehensive microbial variant detection and enhancement of gene assembly. PLoS ONE 9 e112963 (2014).

  • 39th

    Santiago-Rodriguez, T. M. et al. Transcriptome analysis of bacteriophage communities in periodontal health and disease. BMC Genomics 16 549 (2015).

  • 40th

    Haft, D. H. et al. RefSeq: an update of comments and curation of prokaryotic genome. Nucleic Acids Res . 46 D851 – D860 (2018).

  • 41st

    Tatusova, T. et al. NCBI's prokaryotic genome note pipeline. Nucleic Acids Res . 44 6614–6624 (2016).

  • 42nd

    Fouts, D. E. Phage_Finder: Automated Identification and Classification of Prophage Regions in Complete Bacterial Genome Sequences. Nucleic Acids Res . 34 5839-5851 (2006).

  • 43rd

    Ondov, B. D. et al. Mash: fast estimation of genome and metagenome with MinHash. Genome Biol . 17 132 (2016).

  • 44th

    Paradis, E. & Schliep, K. ape 5.0: An environment for modern phylogenetics and evolutionary analyzes in R. Bioinformatics [19659003] 35 526–528 (2019).

  • 45 °.

    Letunic, I. & Bork, P. Interactive tree of life (iTOL) v3: an online tool for viewing and commenting on phylogenetic and other trees. Nucleic Acids Res . 44 W242 – W245 (2016).

  • 46th

    Valentine, R. C., Shapiro, B. M. & Stadtman, E. R. Regulation of glutamine synthetase. XII. Electron microscopy of the enzyme from Escherichia coli . Biochemistry 7 2143–2152 (1968).

  • 47th

    Haas, B. J. et al. Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyro-sequenced PCR amplicons. Genome Res . 21 494–504 (2011).

  • 48th

    Caporaso, J. G. et al. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc. Natl Acad. Sci. United States 108 (Suppl 1), 4516–4522 (2011).

  • 49th

    Chen, P. et al. Addition of saturated long-chain fatty acids maintains the intestinal eubiosis and reduces ethanol-induced liver damage in mice. Gastroenterology 148 203–214.e16 (2015).

  • 50th

    Ryu, H. et al. Development of quantitative PCR assays targeting the 16S rRNA genes of Enterococcus spp. And their application to the identification of enterococcus species in environmental samples. Appl. Environ. Microbiol . 79 196–204 (2013).

  • 51st

    Haas, W., Shepard, BD & Gilmore, MS Two-component regulator from Enterococcus faecalis cytolysin corresponds to quorum sensing autoinduction. Nature 415 84–87 (2002).

  • 52nd

    Page, A. J. et al. Robust prokaryote with high capacity de novo and improvement pipeline for Illumina data. Microb. THROUGH . 2 e000083 (2016).

  • 53rd

    Chen, L. et al. VFDB: a reference database for bacterial virulence factors. Nucleic Acids Res . 33 D325 – D328 (2005).

  • 54th

    Jia, B. et al. SHORT 2017: expansion and model-centered curation of the comprehensive antibiotic resistance database. Nucleic Acids Res . 45 D566 – D573 (2017)

  • 55.

    Seemann, T. Prokka: Quick Commentary for Prokaryotic Genome. Bioinformatics 30 2068–2069 (2014).

  • 56th

    Stamatakis, A. RAxML version 8: a tool for phylogenetic analysis and post analysis of large phylogenies. Bioinformatics 30 1312–1313 (2014).

  • 57th

    Tang, W., Bobeica, SC, Wang, L. & van der Donk, WA CylA is a sequence-specific protease involved in toxin biosynthesis. J. Ind Microbiol. Biotechnol . 46 537–549 (2019).

  • 58th

    Iwaisako, K. et al. Protection against liver fibrosis by a peroxisome proliferator-activated receptor 5 agonist. Proc. Natl Acad. Sci. USA 109 E1369 – E1376 (2012).

  • 59th

    Clarke, TH, Brinkac, LM, Sutton, G. & Fouts, DE GGRaSP: an R package to select representative genomes with Gaussian mixing models. Bioinformatics 34 3032-3034 (2018).


  • Source link